12:20 PM EST - GeneNews Limited : Announced operational and financial results for the three-month period ending March 31, 2018. All amounts are expressed in U.S. dollars. The company reported a consolidated net loss of $0.6 million, or $0.00 loss per common share, as compared with a consolidated net loss of $1.5 million, or $0.02 loss per common share, for the same period in 2017. The $0.9-million decrease in net loss primarily results from a $0.6 million change in revaluation of warrants, by decreases in general and administrative expenses of $0.2 million, in cost of goods sold of $0.1 million, in finance costs of $0.1 million, offset by declines in revenue of $0.2 million. GeneNews Limited
shares T.GEN are trading unchanged at $0.09.
